ACTHREL

This brand name is authorized in United Kingdom, United States

Active ingredients

The drug ACTHREL contains one active pharmaceutical ingredient (API):

1 Corticorelin UNII 56X54T817Q - CORTICORELIN OVINE TRIFLUTATE

Corticorelin results in a rapid and sustained increase of plasma ACTH levels and a near parallel increase of plasma cortisol. In addition corticorelin causes a concomitant and prolonged release of the related proopiomelanocortin peptides β- and γ-lipotropins (β- and γ-LPH) and β-endorphin (β-END). Read about Corticorelin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACTHREL Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01AA01	Corticotropin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01A Anterior pituitary lobe hormones and analogues → H01AA ACTH
Discover more medicines within H01AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 326208
Country: US	FDA, National Drug Code	Identifier(s): 55566-0302